Abrofast-M Tablet PR
Abrofast-M Tablet PR helps prevent and treat asthma and chronic obstructive pulmonary disorder (COPD). It helps relax the muscles of the air passages, thereby making it easier to breathe. It is also used to treat bronchitis.
Abrofast-M Tablet PR
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Abrofast-M Tablet PR helps prevent and treat asthma and chronic obstructive pulmonary disorder (COPD). It helps relax the muscles of the air passages, thereby making it easier to breathe. It is also used to treat bronchitis.
Abrofast-M Tablet PR helps prevent and treat asthma and chronic obstructive pulmonary disorder (COPD). It helps relax the muscles of the air passages, thereby making it easier to breathe. It is also used to treat bronchitis.
Abrofast-M Tablet PR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early, your symptoms may come back, and your condition may worsen. Let your healthcare team know about all other medications you are taking, as some may affect or be affected by this medicine.
The most common side effects are vomiting, heartburn, stomach pain, rash, itching, and breathing difficulty. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. This medicine may also cause dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you. Avoid drinking alcohol while taking this medicine, as it can worsen your sleepiness.
Before taking it, you should tell your doctor if you have any kidney or liver diseases so that your doctor can prescribe a suitable dose for you. You should also tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
03Uses
Treatment and prevention of Asthma
Treatment and prevention of Chronic obstructive pulmonary disease (COPD)
Treatment of Bronchitis
04How To Use
Use it as advised by your doctor or check the label for directions before use. Abrofast-M Tablet PR may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Abrofast-M Tablet PR is a combination of two medicines: acebrophylline and montelukast. Acebrophylline is a mucolytic and helps relax the muscles in the airways. It thins and loosens mucus (phlegm), making it easier to cough out. Montelukast is a leukotriene antagonist. It works by blocking the action of leukotriene, a chemical messenger. This reduces inflammation in the airways and nose to prevent asthma and relieve symptoms of allergies.
06What If You Miss A Dose?
Q: What if you forget to take Abrofast-M Tablet PR?
A: If you miss a dose of Abrofast-M Tablet PR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Treatment and prevention of Asthma
Abrofast-M Tablet PR is a combination of two medicines that can help prevent the onset of an asthma attack if it is taken before exercise or exposure to some “triggers”. These “triggers” may include house dust, pollen, pets, and cigarette smoke. This medicine relaxes the muscles of your airways which makes the air easier to get in and out. It will, therefore, allow you to exercise more freely without worrying about getting symptoms such as wheezing, coughing, and shortness of breath. This enables you to live your life more freely without worrying so much about things that set off your symptoms.
08Side Effects
Vomiting
Heartburn
Stomach pain
Rash
Itching
Breathing problems
09Safety Information
Alcohol:CAUTION
Caution is advised when consuming alcohol with Abrofast-M Tablet PR. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Information regarding the use of Abrofast-M Tablet PR during pregnancy is not available. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Abrofast-M Tablet PR during breastfeeding is not available. Please consult your doctor.
Driving:CONSULT YOUR DOCTOR
It is not known whether Abrofast-M Tablet PR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:CAUTION
Abrofast-M Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Abrofast-M Tablet PR may be needed. Please consult your doctor.
Liver:CAUTION
Abrofast-M Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Abrofast-M Tablet PR may be needed. Please consult your doctor.
10Drug Tips
Abrofast-M Tablet PR should be taken at the same time each day, preferably in the evening after food.
Your doctor may need to take regular blood tests to monitor the level of the drug in your body to make sure that you are taking the right dose.
Your doctor may need to take regular blood test to monitor the level of drug in your body to make sure that you are taking the right dose.
Notify your doctor if you have ever been diagnosed with kidney, liver, or heart disease, or if you have a smoking history. Your dose may need to be adjusted.
Do not discontinue use without consulting your doctor, even if you feel better.
References
Sources and references
Montelukast sodium [EMC Label]. South Ruislip, Middlesex: Aurobindo Pharma – Milpharm Ltd.; 2018. [Accessed 22 Apr. 2019] (online) Available from: View
Pozzi E. Acebrophylline: An airway mucoregulator and anti-inflammatory agent. Monaldi Arch Chest Dis. 2007;67(2):106-15. [Accessed 01 Apr. 2019] (online) Available from: View
Montelukast. Whitehouse Station, New Jersey: Merck & Co., Inc.; 1998 [revised Nov. 2014]. [Accessed 22 Apr. 2019] (online) Available from: View
PubChem. Acebrophylline. [Accessed 01 Apr. 2019] (online) Available from: View
Montelukast [Prescribing Information]. Whitehouse Station, NJ: Merck & Co., Inc.; 2021. [Accessed 12th Sept. 2023] (online) Available from: View
Leeford: Acebrophylline SR 200 mg & Montelukast Sodium [produt Information] [Accessed 12th Sept. 2023] (online) Available from: View
